Lasa Supergenerics has informed that it enclosed a copy of Press Release today titled ‘LASA SUPERGENERICS PAT AT 12.35 Cr up by Robust 362% as compared to Loss of 4.71 Cr in Q3FY22’.
The above information is a part of company’s filings submitted to BSE.